HUP0402112A2 - Process for the preparation of crystalline imipenem - Google Patents

Process for the preparation of crystalline imipenem

Info

Publication number
HUP0402112A2
HUP0402112A2 HU0402112A HUP0402112A HUP0402112A2 HU P0402112 A2 HUP0402112 A2 HU P0402112A2 HU 0402112 A HU0402112 A HU 0402112A HU P0402112 A HUP0402112 A HU P0402112A HU P0402112 A2 HUP0402112 A2 HU P0402112A2
Authority
HU
Hungary
Prior art keywords
preparation
imipenem
crystalline imipenem
crystalline
atienamycin
Prior art date
Application number
HU0402112A
Other languages
Hungarian (hu)
Inventor
Bishwa Prakash Rai
Neera Tewari
Yatendra Kumar
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of HUP0402112A2 publication Critical patent/HUP0402112A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A jelen találmány tárgya költséghatékony és iparilag előnyös eljárásnagy tisztaságú imipenem előállítására. Az imipenem monohidrát atienamycin N-formimid származéka és (I) szerkezeti képletű: ÓThe subject of the present invention is a cost-effective and industrially advantageous process for the production of high-purity imipenem. Imipenem monohydrate is an N-formimide derivative of atienamycin and has the structural formula (I): Ó

HU0402112A 2001-11-16 2002-11-18 Process for the preparation of crystalline imipenem HUP0402112A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1152DE2001 2001-11-16
PCT/IB2002/004804 WO2003042215A1 (en) 2001-11-16 2002-11-18 Process for the preparation of crystalline imipenem

Publications (1)

Publication Number Publication Date
HUP0402112A2 true HUP0402112A2 (en) 2005-02-28

Family

ID=11097136

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402112A HUP0402112A2 (en) 2001-11-16 2002-11-18 Process for the preparation of crystalline imipenem

Country Status (15)

Country Link
US (1) US7332600B2 (en)
EP (1) EP1448563A1 (en)
JP (1) JP2005509037A (en)
KR (1) KR20050044506A (en)
CN (1) CN1608066A (en)
AR (1) AR037551A1 (en)
BR (1) BR0214209A (en)
CA (1) CA2467427A1 (en)
EA (1) EA200400682A1 (en)
HR (1) HRP20040552A2 (en)
HU (1) HUP0402112A2 (en)
MX (1) MXPA04004604A (en)
PL (1) PL368984A1 (en)
WO (1) WO2003042215A1 (en)
ZA (1) ZA200403961B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL373527A1 (en) * 2001-05-18 2005-09-05 Ranbaxy Laboratories Limited Process for the isolation of crystalline imipenem
JP2005023081A (en) * 2003-06-11 2005-01-27 Api Corporation Crystal of arbutin and method for preparation of the same
US8233959B2 (en) 2003-08-22 2012-07-31 Dexcom, Inc. Systems and methods for processing analyte sensor data
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
EP4218548A1 (en) 2006-03-09 2023-08-02 Dexcom, Inc. Systems and methods for processing analyte sensor data
US8222427B2 (en) * 2006-12-15 2012-07-17 Merck Sharp & Dohme Corp. Bisulfite purification of an alpha-keto amide
US8621008B2 (en) 2007-04-26 2013-12-31 Mcafee, Inc. System, method and computer program product for performing an action based on an aspect of an electronic mail message thread
US8199965B1 (en) 2007-08-17 2012-06-12 Mcafee, Inc. System, method, and computer program product for preventing image-related data loss
US20130276061A1 (en) 2007-09-05 2013-10-17 Gopi Krishna Chebiyyam System, method, and computer program product for preventing access to data with respect to a data access attempt associated with a remote data sharing session
US8293924B2 (en) * 2007-10-08 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
US8893285B2 (en) 2008-03-14 2014-11-18 Mcafee, Inc. Securing data using integrated host-based data loss agent with encryption detection
US9077684B1 (en) 2008-08-06 2015-07-07 Mcafee, Inc. System, method, and computer program product for determining whether an electronic mail message is compliant with an etiquette policy
CN101891745B (en) * 2010-07-20 2012-06-13 深圳市海滨制药有限公司 Method for preparing imipenem monohydrate crystal
CN101891744B (en) * 2010-07-20 2012-06-13 深圳市海滨制药有限公司 Method for preparing Imipenem monohydrate crystals
WO2012081033A2 (en) * 2010-12-06 2012-06-21 Sequent Scientific Limited A process for preparation of imipenem
CN103524508B (en) * 2013-09-02 2016-03-30 上海龙翔生物医药开发有限公司 A kind of crystallization method of Imipenem monohydrate
CN113135916A (en) * 2020-01-20 2021-07-20 鲁南制药集团股份有限公司 Palladium removing method for imipenem preparation process
CN111747959B (en) * 2020-05-15 2022-02-11 深圳市海滨制药有限公司 Preparation method of imipenem raw material medicine
CN114671877B (en) * 2022-02-18 2023-05-16 珠海联邦制药股份有限公司 Refining method of imipenem

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE268240C (en)
JPS606957B2 (en) 1973-04-10 1985-02-21 ブリストル マイヤ−ズ カンパニ− Method for producing antibiotic derivatives
US4194047A (en) 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4260543A (en) 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
DK153486C (en) 1978-07-03 1988-11-28 Merck & Co Inc ANALOGY PROCEDURE FOR THE PREPARATION OF CRYSTALLINIC N-FORMIMIDOYL-THIENAMYCINE MONOHYDRATE
US4292436A (en) 1980-06-25 1981-09-29 Merck & Co., Inc. Process for the preparation of N-protected N-formimidoyl 2-aminoethanethiol
US5061730A (en) * 1987-01-26 1991-10-29 Fujisawa Pharmaceutical Co., Ltd. Carboxylic acid derivatives
DD268240A1 (en) * 1987-12-05 1989-05-24 Univ Schiller Jena PROCESS FOR THE PRODUCTION OF HIGH-PURITY OF 2-HYDROXY-4-ALKOXYBENZOPHENONES SUITABLE FOR APPLICATION IN OPTICS OF POLYMERIC MATERIALS
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
CA2023144A1 (en) * 1989-08-21 1991-02-22 Frank P. Dininno 2-(quinoliniumalkyl and isoquinoliniumalkyl)-phenyl carbapenem antibacterial agents
JPH03256262A (en) 1990-03-07 1991-11-14 Nec Corp Magnetic disk device
US5240920A (en) * 1990-10-11 1993-08-31 Merck & Co., Inc. 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents
JPH06256262A (en) * 1993-03-08 1994-09-13 Sekiyu Sangyo Kasseika Center Purification of 2,6-naphthalene dicarboxylic acid dimethyl ester
US5621084A (en) * 1994-04-05 1997-04-15 Pfizer Inc. Process for removal of allyl group or allyloxycarbonyl group
BR9606624A (en) 1995-09-08 1997-11-11 Bracco Int Bv Process for the crystallization of (s) -n, n'-bisÚ2-hydroxy-1- (hydroxymethyl) ethyl¾-5-Ú (2-hydroxy-1-oxopropyl) amino¾-2,4,6-triiodo-1,3 -benzonodicar-boxamide from water
DE69734779T2 (en) 1996-03-14 2006-07-27 Novozymes A/S INCREASED LOYALTY ON A CRYSTALLIZED PROTEIN USING A SOLID ADSORPTION MATERIAL
CN1109688C (en) * 1999-01-12 2003-05-28 中国药品生物制品检定所 Preparation and application of tazobactam semihydrate
DE60014047T2 (en) 1999-03-22 2006-02-23 Purac Biochem B.V. PROCESS FOR PURIFYING MILKYLIC ACID ON INDUSTRIAL BASIS
GB9925215D0 (en) 1999-10-26 1999-12-22 Cerestar Holding Bv Process for the manufacture of citric acid
DK1270575T3 (en) * 2000-03-31 2006-01-16 Shionogi & Co Hitherto crystalline form of a pyrrolidylthiocarbapenem derivative
IN191798B (en) 2000-11-03 2004-01-03 Ranbaxy Lab Ltd
AR035728A1 (en) * 2001-01-16 2004-07-07 Merck & Co Inc PERFECTED PROCESS FOR CARBAPENEM SYNTHESIS
PL373527A1 (en) * 2001-05-18 2005-09-05 Ranbaxy Laboratories Limited Process for the isolation of crystalline imipenem
CA2457642C (en) * 2001-09-26 2009-01-06 Merck & Co., Inc. Crystalline forms of ertapenem sodium
KR100628676B1 (en) * 2001-09-26 2006-09-27 머크 앤드 캄파니 인코포레이티드 Process for making carbapenem compounds

Also Published As

Publication number Publication date
KR20050044506A (en) 2005-05-12
WO2003042215A1 (en) 2003-05-22
MXPA04004604A (en) 2004-09-10
ZA200403961B (en) 2005-09-19
JP2005509037A (en) 2005-04-07
EA200400682A1 (en) 2004-10-28
EP1448563A1 (en) 2004-08-25
AR037551A1 (en) 2004-11-17
HRP20040552A2 (en) 2004-10-31
US7332600B2 (en) 2008-02-19
BR0214209A (en) 2004-10-26
US20050004359A1 (en) 2005-01-06
PL368984A1 (en) 2005-04-04
CN1608066A (en) 2005-04-20
CA2467427A1 (en) 2003-05-22

Similar Documents

Publication Publication Date Title
HUP0402112A2 (en) Process for the preparation of crystalline imipenem
HUP0302345A2 (en) Novel triazolo pyrimidine compounds, their intermediates and process for their preparation
HUP0002987A2 (en) Dicyclohexyl-amine salt of cefdinir and process for the preparation of the salt and subsequent liberation of the free compound
HK1078857A1 (en) Intermediates for the production of beraprost and its salts
YU94103A (en) Novel sulfonic acid derivatives
AU2001272504A1 (en) 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof
HU0201083D0 (en)
EP1460065A4 (en) Processes for production of cyclic diamine compounds or salts thereof
HUP0302534A2 (en) Preparation of mandelic acid derivatives
AU2002342915A1 (en) Process for preparation of alpha-hydroxycarboxylic acid amides
WO2005080329A3 (en) Process for manufacture of racemic carvedilol
MXPA03010548A (en) Process for the isolation of crystalline imipenem.
HUP0400767A2 (en) An improved process for preparing pure ondansetron hydrochloride dihydrate
CA2468435A1 (en) Process for the production of an immunosuppressant
AU3590801A (en) One-pot synthesis of alkyl 3-cyclopropylamino-2-(2,4-dibromo-3-(difluoromethoxy)benzoyl -2-propenoate as a useful intermediate for antibacterial quinolone medicaments
HUP0000726A2 (en) Process for manufacturing fluconazole
GB0320738D0 (en) Novel process
HUP0400606A2 (en) 2-methylindole-4-acetic acid, process for producing the same, and process for producing intermediate thereof
AP2003002912A0 (en) Process for the preparation of amorphouse cilastatin sodium
HUP0303153A2 (en) Preparation of n-methylparoxetine and its intermediate compounds
HUP0303853A2 (en) Process for preparation of nitrile compound
IL162756A0 (en) Process for production of dimethyl-2-formylcyclopropanecarboxylic acid derivatives
AR034824A1 (en) ACITRETINE PREPARATION PROCESS
AU2002346372A1 (en) Process for the production of l-dopa ethyl ester
ATE479649T1 (en) INTERMEDIATE PRODUCTS AND PROCESS FOR PRODUCING AROMATIC DERIVATIVES OF 1-ADAMANTANE

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: RANBAXY LABORATORIES LIMITED, IN

Free format text: FORMER OWNER(S): RANBAXY LABORATORIES LIMITED, IN

FD9A Lapse of provisional protection due to non-payment of fees